Author

Yiying Zhu

Tsinghua UniversityORCID 0000-0002-5237-3525Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:drug response / drug discovery· 2 Research Focus:benchmarking· 1 Research Focus:database / resource· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Annan Qian· 2 shared Mengping LongiD· 2 shared Shaojun TangiD· 2 shared Taobo HuiD· 2 shared Tianlong He· 2 shared Wenhao ShiiD· 2 shared Yuqiao LiuiD· 2 shared Fangzhou Xie· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Annan Qian

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyScientific ReportsPeer-reviewedNov 13, 2025

Proteogenomic Characterization of Triple-Negative Apocrine Carcinoma Reveals Molecular Features of Progression and Chemotherapy Response

Yiying Zhu, Mengping Long, Wenhao Shi…·Shaojun Tang

This study identifies molecular features of triple-negative apocrine carcinoma through proteogenomic analysis, revealing resistance mechanisms and suggesting alternative therapeutic strategies.

DOI 10.1038/s41598-025-23449-2

humanproteomics

𝕏 PostBluesky

Cancer BiologyiSciencePeer-reviewedSep 5, 2025

The Whole Proteome, Phosphoproteome, and Glycoproteome Landscape of Pan-Cancer Cell Lines Profiled by Mass Spectrometry and Reverse Phase Protein Array

Wenhao Shi, Tianlong He, Nan Wang…·Yiying Zhu

The paper profiles proteome, phosphoproteome, and glycoproteome of 54 cancer cell lines using MS and RPPA, revealing tissue-specific patterns and drug targets.

2 citations

humanproteomics

𝕏 PostBluesky

Cancer BiologyPROTEOMICSPeer-reviewedNov 16, 2024

Parallel Analyses by Mass Spectrometry (MS) and Reverse Phase Protein Array (RPPA) Reveal Complementary Proteomic Profiles in Triple-Negative Breast Cancer (TNBC) Patient Tissues and Cell Cultures

Nan Wang, Yiying Zhu, Lianshui Wang…·Zhiyong Ding

The paper compares Mass Spectrometry (MS) and Reverse Phase Protein Array (RPPA) in TNBC samples to assess their performance and identify complementary proteomic profiles.

6 citations

humanproteomics

𝕏 PostBluesky